IndustryCompany release

Charles River to acquire Frontage's Exton bioanalysis and DMPK businesses for about $470m

🇺🇸 Charles River Laboratories International, Inc. (CRL) · Mon 09 Nov 2026

The CRO has signed definitive agreements for the Pennsylvania units, with up to $75m in further performance-based payments, through a consortium structure that first takes Frontage private.

Charles River Laboratories International announced on 9 November 2026 that it has signed definitive agreements to buy the bioanalysis and drug metabolism and pharmacokinetics (DMPK) businesses of Frontage Holdings in Exton, Pennsylvania. The price is about $470m in cash, plus up to $75m in performance-based payments.

The transaction runs through a consortium that includes Tigermed and Dr. Song Li. Under the structure described, the consortium would first take Frontage private, and Charles River would then acquire the Exton businesses.

Charles River said the deal would expand its clinical bioanalysis capacity, including a CLIA-certified central laboratory. CLIA certification refers to the US Clinical Laboratory Improvement Amendments framework, which sets quality standards for laboratories that test human samples.

Closing is expected in the first half of 2027. It remains subject to shareholder approval, regulatory approvals and approval from the Cayman court.

What it means for your team

  • Sponsors with studies at Frontage's Exton sites should expect a change of ownership at the site and may wish to ask about continuity of bioanalytical and DMPK services and quality agreements.
  • Quality teams may want to check how audit status, data-integrity commitments and sample-handling arrangements would carry over after closing in the first half of 2027.
  • Vendor-management teams could review concentration risk and contract terms as clinical bioanalysis capacity consolidates under one provider.

Company's press release (SEC filing): Charles River Laboratories International, Inc. ↗

Article written by VigiEye from the official source (Charles River Laboratories International, Inc.). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →